REGENXBIO Inc. (RGNX)

NASDAQ: RGNX · Real-Time Price · USD

13.41

-0.45 (-3.25%)

Jan 27, 2026, 4:00 PM EST - Market closed

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Gene Therapy	90.24M	Log In	Log In	Log In	Log In	Upgrade
Gene Therapy Growth	-19.94%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
International	61.36M	Log In	Log In	Log In	Log In	Upgrade
International Growth	-1.02%	Log In	Log In	Log In	Log In	Upgrade
United States	28.88M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-26.81%	Log In	Log In	Log In	Log In	Upgrade
Germany	-	Log In	Log In	Log In	Log In	Upgrade
Bermuda	-	Log In	Log In	Log In	Log In	Upgrade